APA Citation

Zhao, M., Scott, S., Evans, K. W., Yuca, E., Saridogan, T., Zhang, X., . . . Meric-Bernstam, F. (2021). Combining neratinib with CDK4/6, mTOR and MEK inhibitors in models of HER2-positive cancer. Clin Cancer Res.

Chicago Style Citation

Zhao, Ming, et al. "Combining Neratinib With CDK4/6, MTOR and MEK Inhibitors in Models of HER2-positive Cancer." Clin Cancer Res 2021.

MLA Citation

Zhao, Ming, et al. "Combining Neratinib With CDK4/6, MTOR and MEK Inhibitors in Models of HER2-positive Cancer." Clin Cancer Res 2021.

Warning: These citations may not always be 100% accurate.